JP2022519409A5 - - Google Patents
Info
- Publication number
- JP2022519409A5 JP2022519409A5 JP2021503582A JP2021503582A JP2022519409A5 JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5 JP 2021503582 A JP2021503582 A JP 2021503582A JP 2021503582 A JP2021503582 A JP 2021503582A JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- human stem
- mitochondria
- human
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701783P | 2018-07-22 | 2018-07-22 | |
| US62/701,783 | 2018-07-22 | ||
| PCT/IL2019/050828 WO2020021541A1 (en) | 2018-07-22 | 2019-07-22 | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519409A JP2022519409A (ja) | 2022-03-24 |
| JP2022519409A5 true JP2022519409A5 (cg-RX-API-DMAC10.html) | 2022-07-29 |
| JP7633148B2 JP7633148B2 (ja) | 2025-02-19 |
Family
ID=69181398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503582A Active JP7633148B2 (ja) | 2018-07-22 | 2019-07-22 | 機能的ミトコンドリアで富化された幹細胞を用いたミトコンドリア増強療法 |
Country Status (11)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL282198B2 (en) | 2011-09-11 | 2025-11-01 | Minovia Therapeutics Ltd | Compositions of functional mitochondria and uses thereof |
| WO2020021539A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| WO2020021535A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| US12329781B2 (en) | 2018-07-22 | 2025-06-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of renal diseases |
| US12502408B2 (en) | 2018-07-22 | 2025-12-23 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| EP3823644A4 (en) | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| JP7524157B2 (ja) | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| TWI789723B (zh) * | 2020-03-20 | 2023-01-11 | 台灣粒線體應用技術股份有限公司 | 粒線體用於治療或/及預防腎臟損傷相關疾病之用途 |
| CN115427052A (zh) * | 2020-03-31 | 2022-12-02 | 米诺维亚治疗公司 | 线粒体加强疗法 |
| MX2022012157A (es) * | 2020-03-31 | 2023-02-15 | Minovia Therapeutics Ltd | Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas. |
| US20230190822A1 (en) * | 2020-05-05 | 2023-06-22 | Pluri Biotech Ltd. | Methods and compositions for enrichment of target cells |
| JP2024504160A (ja) * | 2021-01-25 | 2024-01-30 | ミノヴィア セラピューティクス リミテッド | ミトコンドリア富化細胞の同定法 |
| WO2022243906A1 (en) * | 2021-05-18 | 2022-11-24 | Imel Biotherapeutics, Inc. | Methods and compositions for generating mitochondria replaced lymphoid cells |
| CN115554317A (zh) * | 2021-07-01 | 2023-01-03 | 深圳市脉唐生物科技有限公司 | 一种用于治疗肿瘤的药物组合物、试剂盒及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472378B2 (en) | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| CA2688125A1 (en) * | 2007-05-02 | 2008-11-13 | The Mclean Hospital Corporation | Methods and compositions for mitochondrial replacement therapy |
| CN102266350A (zh) * | 2011-07-20 | 2011-12-07 | 黄必录 | 逆转干细胞衰老的方案 |
| CN102293178A (zh) * | 2011-08-28 | 2011-12-28 | 黄必录 | 使个体去衰老的方法 |
| CN103976935A (zh) * | 2014-05-28 | 2014-08-13 | 广州市白云区天芳化妆品厂 | 一种抗衰原液及其制备方法 |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| WO2016037587A1 (en) * | 2014-09-11 | 2016-03-17 | Taiwan Mitochondrion Applied Technology Co., Ltd | Pharmaceutical compositions for treating degenerative neurological disease with mitocells |
| US20180030413A1 (en) * | 2015-02-26 | 2018-02-01 | Minovia Therapeutics Ltd. | Mammalian cells enriched with functional mitochondria |
| WO2018088874A1 (ko) | 2016-11-14 | 2018-05-17 | 주식회사 파이안바이오테크놀로지 | 외래 미토콘드리아를 세포로 전달하는 방법 |
| CN110022884A (zh) | 2016-11-30 | 2019-07-16 | 白雁生物技术公司 | 含有线粒体的药物组合物 |
-
2019
- 2019-07-22 WO PCT/IL2019/050828 patent/WO2020021541A1/en not_active Ceased
- 2019-07-22 IL IL280162A patent/IL280162B2/en unknown
- 2019-07-22 US US17/252,674 patent/US20210322485A1/en not_active Abandoned
- 2019-07-22 MX MX2021000954A patent/MX2021000954A/es unknown
- 2019-07-22 CN CN201980054078.2A patent/CN112601532A/zh active Pending
- 2019-07-22 JP JP2021503582A patent/JP7633148B2/ja active Active
- 2019-07-22 AU AU2019311862A patent/AU2019311862B2/en active Active
- 2019-07-22 KR KR1020217004453A patent/KR20210035829A/ko not_active Ceased
- 2019-07-22 EP EP19840685.2A patent/EP3823642A4/en active Pending
- 2019-07-22 BR BR112021001010-6A patent/BR112021001010A2/pt not_active IP Right Cessation
- 2019-07-22 CA CA3106188A patent/CA3106188A1/en active Pending
-
2024
- 2024-08-27 US US18/817,206 patent/US20240415894A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhidu et al. | Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities | |
| US12605410B2 (en) | Mitochondria-enriched genetically engineered cells and uses thereof | |
| US20240415894A1 (en) | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria | |
| EP1763538B1 (en) | Genetically engineered cells for therapeutic applications | |
| Walter et al. | Endothelial progenitor cells: regulation and contribution to adult neovascularization | |
| US12551504B2 (en) | Mitochondrial augmentation therapy of pancreatic diseases | |
| ES2575165T3 (es) | Células madre del estroma derivadas de tejido adiposo para su uso en el tratamiento de SRIS | |
| JP2021532091A5 (cg-RX-API-DMAC10.html) | ||
| US20030091547A1 (en) | Platelet-derived growth factor protection of cardiac myocardium | |
| KR20050000399A (ko) | 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도 | |
| JP2021532094A5 (cg-RX-API-DMAC10.html) | ||
| JP2021532095A (ja) | 肝臓疾患のミトコンドリア増強療法 | |
| JP2021532094A (ja) | 筋疾患のミトコンドリア増強療法 | |
| TW201130977A (en) | Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood | |
| JP2023519744A5 (cg-RX-API-DMAC10.html) | ||
| Atoui et al. | Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance | |
| US20170355959A1 (en) | Methods for mobilising populations of stem cells | |
| EP1771196B1 (en) | Ccr ligands for stem cell homing | |
| Liang et al. | Intravenously Administered Human Umbilical Cord‐Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance Following Infarction via Immune Modulation | |
| JP2021531281A5 (cg-RX-API-DMAC10.html) | ||
| BRPI0620523A2 (pt) | método de aumentar o potencial de implante e de atração celular, método de preparar células para transplante em um sujeito, população de células e composição farmacêutica | |
| CN116987666A (zh) | 靶向sting通路制备治疗性nk细胞 | |
| US12385011B2 (en) | Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells | |
| Shichkin | Stem cells of the thymus | |
| KR101673318B1 (ko) | 은나노 물질로 처리된 중간엽 줄기세포 또는 그 배양액을 유효성분으로 포함하는 상처 치료용 세포치료제 조성물 |